Honoured to speak on #FMT #LBPs at the #EHMSG meeting today in session with Nicolas Benech and Jens Walter. Thanks to Gianluca Ianiro for organising, and for even getting a @nobelprize.bsky.social winner for Physics to speak to us, Giorgio Parisi! @imperialmdr.bsky.social #microbiomeclinicians

🆕 Global Commission proposes overhaul of obesity diagnosis – going beyond BMI to define when obesity is a disease. Find out more: hubs.li/Q030v_j_0

New research - Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial www.thelancet.com/journals/lan... #GastroSky #OncSky #MedSky @oncoalert.bsky.social

Pleased that #FARGO - a randomised, multicentre, placebo-controlled phase IIa trial of #FMT to treat #PSC - is running and recruiting. Have a look at the protocol paper out now in #BMJOpen: doi.org/10.1136/bmjo... @pscsupport.bsky.social @cholestasisdoc.bsky.social

New from us: our trial protocol for faecal microbiota transplantation to treat people living with PSC and IBD. Actively recruiting! @bhmullish.bsky.social @nabilquraishi.bsky.social @alanmcn1.bsky.social @pscsupport.bsky.social bmjopen.bmj.com/content/bmjo...

Agree that mRNA vaccine technology needs deeper evaluation. @fda.gov should provide further details in due course. www.bmj.com/content/387/...

New work from us: Oral vancomycin is associated with attenuation in IBD activity in people with PSC. We also studied changes in gut microbiome profile, and key transcriptomic and metabolomic features. academic.oup.com/ecco-jcc/adv...

Great work by Nabil Quraishi, Palak Trivedi and many others - unravelling the positive impact of #vancomycin in #PSC #IBD by altering interactions between the host, #microbiome, and #metabolome. Now in #JCC: academic.oup.com/ecco-jcc/adv... #GastroSky